Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Rachel Haurwitz — FY2025 total compensation $1,840,965

Rachel Haurwitz is President and chief executive officer of Caribou Biosciences, Inc. (CRBU). The company reported total compensation of $1,840,965 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$667,534
Bonus$312,072
Stock awards$192,818
Option awards$654,541
Non-equity incentive plan$0
Pension and non-qualified deferred compensation$0
All other compensation$14,000
Total$1,840,965

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Caribou Biosciences, Inc. filed May 1, 2026, accession 0001619856-26-000028.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President and chief executive officer$667,534$312,072$192,818$654,541$0$0$14,000$1,840,965
FY2024President and chief executive officer$508,733$310,387$808,347$2,571,978$0$0$13,800$4,213,245
FY2023President and chief executive officer$623,150$342,733$2,137,464$13,200$3,116,547
FY2021President and chief executive officer$527,386$319,069$5,391,864$11,600$6,249,919
FY2020President and chief executive officer$450,000$202,500$11,400$663,900

Totals as disclosed in each year's own compensation disclosure for Caribou Biosciences, Inc..

04

The other named executive officers of Caribou Biosciences, Inc.

Named executive officerRoleFY2025 total
Rachel Haurwitz this pagePresident and chief executive officer$1,840,965
Sriram RyaliChief financial officer$1,029,413
Barbara McClungChief legal officer$919,574

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Caribou Biosciences, Inc. compensation brief.

05

The company page

Rachel Haurwitz's compensation sits inside Caribou Biosciences, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Caribou Biosciences, Inc. (CRBU) compensation brief